A Restrictive Use of Oral Glucocorticoids in Systemic Lupus Erythematosus Prevents Damage Without Worsening Long-Term Disease Control: An Observational Study
Arthritis Care and Research - United States
doi 10.1002/acr.23322
Full Text
Open PDFAbstract
Available in full text
Categories
Date
March 7, 2018
Authors
Publisher
Wiley